Swiss (SMI) Life Sciences Industry Analysis

UpdatedSep 03, 2025

DataAggregated Company Financials

Companies7

7D-3.3%
3M0.6%
1Y-6.1%
YTD1.0%

Over the last 7 days, the Life Sciences industry has dropped 1.4%, driven by declines from every company within the industry. The industry has fallen 5.5% in the last year. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Wed, 03 Sep 2025	CHF 52.4b	CHF 10.7b	CHF 1.1b	33x	47.5x	4.9x
Fri, 01 Aug 2025	CHF 54.2b	CHF 10.7b	CHF 1.1b	34.6x	47.2x	5.1x
Sun, 29 Jun 2025	CHF 52.8b	CHF 10.1b	CHF 1.0b	33.6x	50.8x	5.2x
Tue, 27 May 2025	CHF 52.6b	CHF 10.1b	CHF 1.0b	31.4x	50.6x	5.2x
Thu, 24 Apr 2025	CHF 51.4b	CHF 10.1b	CHF 1.0b	29.2x	50.2x	5.1x
Sat, 22 Mar 2025	CHF 53.6b	CHF 10.1b	CHF 1.0b	33.1x	52.6x	5.3x
Mon, 17 Feb 2025	CHF 57.1b	CHF 10.1b	CHF 1.0b	36.4x	56.7x	5.7x
Wed, 15 Jan 2025	CHF 52.6b	CHF 10.2b	CHF 943.4m	34.2x	55.8x	5.2x
Fri, 13 Dec 2024	CHF 54.4b	CHF 10.2b	CHF 943.6m	39.3x	57.7x	5.3x
Sun, 10 Nov 2024	CHF 55.9b	CHF 10.2b	CHF 943.4m	43.8x	59.2x	5.5x
Tue, 08 Oct 2024	CHF 54.3b	CHF 10.2b	CHF 943.5m	41.5x	57.5x	5.3x
Thu, 05 Sep 2024	CHF 56.2b	CHF 10.2b	CHF 937.1m	44x	60x	5.5x
Sat, 03 Aug 2024	CHF 57.4b	CHF 10.2b	CHF 924.3m	44.5x	62.1x	5.6x
Mon, 01 Jul 2024	CHF 51.2b	CHF 10.3b	CHF 1.0b	44x	51.1x	5x
Wed, 29 May 2024	CHF 53.0b	CHF 10.3b	CHF 1.0b	44x	53x	5.2x
Fri, 26 Apr 2024	CHF 53.9b	CHF 10.3b	CHF 1.0b	43.3x	53.9x	5.3x
Sun, 24 Mar 2024	CHF 57.2b	CHF 10.2b	CHF 1.0b	45.9x	56.9x	5.6x
Tue, 20 Feb 2024	CHF 50.0b	CHF 10.2b	CHF 1.0b	46.3x	49x	4.9x
Thu, 18 Jan 2024	CHF 41.1b	CHF 9.8b	CHF 1.5b	30.9x	27.5x	4.2x
Sat, 16 Dec 2023	CHF 41.2b	CHF 9.8b	CHF 1.5b	32.6x	27.6x	4.2x
Mon, 13 Nov 2023	CHF 39.6b	CHF 9.8b	CHF 1.5b	27.5x	26.5x	4x
Wed, 11 Oct 2023	CHF 47.1b	CHF 9.8b	CHF 1.5b	32.2x	31.5x	4.8x
Fri, 08 Sep 2023	CHF 52.7b	CHF 9.8b	CHF 1.5b	36.3x	35.4x	5.4x
Sun, 06 Aug 2023	CHF 52.9b	CHF 9.8b	CHF 1.5b	35.3x	34.2x	5.4x
Tue, 04 Jul 2023	CHF 54.8b	CHF 9.7b	CHF 1.6b	35.7x	33.6x	5.7x
Thu, 01 Jun 2023	CHF 59.7b	CHF 9.7b	CHF 1.6b	36.8x	36.6x	6.2x
Sat, 29 Apr 2023	CHF 59.1b	CHF 9.7b	CHF 1.6b	40.9x	36.2x	6.1x
Mon, 27 Mar 2023	CHF 55.6b	CHF 9.7b	CHF 1.7b	40.3x	33.6x	5.8x
Wed, 22 Feb 2023	CHF 58.8b	CHF 9.6b	CHF 1.6b	34.2x	35.9x	6.2x
Fri, 20 Jan 2023	CHF 52.7b	CHF 9.2b	CHF 1.3b	40x	39.7x	5.7x
Sun, 18 Dec 2022	CHF 49.9b	CHF 9.2b	CHF 1.3b	36.7x	37.6x	5.4x
Tue, 15 Nov 2022	CHF 54.6b	CHF 9.2b	CHF 1.3b	41.5x	41.1x	5.9x
Thu, 13 Oct 2022	CHF 49.9b	CHF 9.2b	CHF 1.3b	39.3x	37.5x	5.4x
Sat, 10 Sep 2022	CHF 54.6b	CHF 9.2b	CHF 1.3b	43.3x	42.2x	6x

Price to Earnings Ratio

42.2x

Sat, 10 Sep 2022

Current Industry PE

Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 48.3x which is higher than its 3-year average PE of 44.9x.

The industry is trading close to its 3-year average PS ratio of 5.3x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have declined 5.2% per year over the last three years.
Meanwhile revenues for these companies have grown 5.1% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.